You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 19 A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study)

Citation Tools

Article menu

Download PDFPDF

Plenary sessions
Plenary 3
IGCS19-0619
19 A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study)
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Macchia G, Lazzari R, Colombo N, et al
19 A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study)
International Journal of Gynecologic Cancer 2019;29:A12.